Lu Jiang

26 items found for " Lu Jiang"

Posts (12)

Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
After discussing the fundamentals and applications of mutagenesis in GPCR studies (Lu, 2024), a case Reference Cam Sinh Lu. (2024, September 3).
Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
factors, including ETS, c-Jun, and Fos, modulating gene expression and influencing cellular functions (Lu Lu, N., & Malemud, C. J. (2019).
GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
This Week’s Highlights: Congrats to: Our contributor, Cam Sinh Lu , who has just released an incredible team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M Payne , Cam Sinh Lu

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Dai , Wen-Fang Wang , Hao Zhang , Chao-Fu Wang , Tong Yin , Shu Cheng , Hui-Juan Zhong , Shan-He Yu , Lu Jiang , Sheng-Yue Wang , Hai Fang , Rui-Hong Zhang , Yue Zhu , Hong-Mei Yi , Xu-Feng Jiang , Jia-Yi
Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells
Authors Trang T T Nguyen , Wen Lu , Wandi S Zhu , K Mark Ansel , Hong-Erh Liang , Arthur Weiss .
Ep 150 with Dr GPCR Team
GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash Cam Sinh Lu on the web LinkedIn Dr.